Dbouk, HA, Weil, LM, Perera, GKS, Dellinger, MT, Pearson, G, Brekken, RA,and Cobb, MH. Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK. Proceedings of the National Academy of Sciences USA 2014; 111(45): 15999-16004.
Vadas, O, Dbouk, HA*, Shymanets, A*, Perisic, O, Burke JE, Abi Saab, WF, Khalil, BD, Harteneck, C,Bresnick, AR, Nurnberg, B, Backer, JM, and Williams, RL. Molecular determinants of PI3Kγ-mediated activation downstream of GPCRs. Proceedings of the National Academy of Sciences USA 2013 Nov 19; 110(47): 18862-18867.
Dbouk, HA, Khalil, BD, Wu, H, Shymanets, A, Nürnberg,B, and Backer, JM. Characterization of a tumor-associated activating mutation of the p110β PI 3-kinase. PLoS One 2013 May; 8(5):e63833.
Dou, Z, Pan, JA, Dbouk,HA, Ballou, LM, DeLeon, JL, Fan, Y, Chen, JS, Liang, Z, Li, G, Backer, JM,Lin, RZ, and Zong, WX. Class IA PI3-kinase p110β subunit promotes autophagy through Rab5 small GTPase in response to growth factor limitation. Molecular Cell 2013 Apr; 50(1): 29-42.
Dbouk, HA and Backer, JM. Novel approaches to inhibitor design for the p110β PI3-Kinase. Trends in Pharmacological Sciences 2013 Mar; 34(3): 149-153.
Dbouk, HA, Vadas, O, Williams, RL, and Backer JM. PI3Kβ downstream of GPCRs – Partners in Oncogenicity. Oncotarget 2012 Dec; 3(12): 1485-1486.
Dbouk, HA*, Vadas, O*,Shymanets, A, Burke, JE, Salamon, RS,Khalil, BD, Perisic, O, Shepherd, PR, Harteneck,C, Harden, TK, Smrcka, AV, Taussig, R,Bresnick, AR, Nürnberg, B, Williams, RL,and Backer, JM. G Protein-Coupled Receptor-mediated activation of p110β by Gβγis required for cellular transformation and invasiveness. Science Signaling 2012 Dec 4; 5, ra89.